Insights

Innovative Pipeline Agenus' comprehensive immuno-oncology pipeline, including antibody therapeutics, adoptive cell therapies, and adjuvants, presents opportunities to expand partnerships with biotech firms and healthcare providers seeking advanced cancer treatment solutions.

Financial Growth With revenues estimated between $100M and $250M and recent positive earnings outlooks, Agenus is positioned as a strong candidate for investments and collaborations, especially with companies looking to leverage emerging immunotherapy technologies.

Recent Milestones Upcoming data milestones and strategic updates announced for 2026 indicate potential for new product launches or clinical partnerships, making timely engagement with R&D teams valuable for joint development opportunities.

Market Expansion Agenus' focus on expanding patient populations benefiting from immunotherapy suggests the company is open to collaborations in new markets or with organizations focused on infectious disease treatments through innovative immunological approaches.

Technological Edge Utilization of advanced tech stacks such as Akamai, Adobe Tag Manager, and Agiloft signals a modern, digitally engaged company receptive to strategic technology partnerships that can enhance clinical trials, data management, or digital outreach.

Agenus Tech Stack

Agenus uses 8 technology products and services including WordPress, Font Awesome, Culture Amp, and more. Explore Agenus's tech stack below.

  • WordPress
    Content Management System
  • Font Awesome
    Font Scripts
  • Culture Amp
    Human Resource Management System
  • jQuery UI
    Javascript Libraries
  • Agiloft
    Project Management
  • HSTS
    Security
  • Akamai Web Application Protector
    Security
  • Adobe Tag Manager
    Tag Management

Media & News

Agenus's Email Address Formats

Agenus uses at least 1 format(s):
Agenus Email FormatsExamplePercentage
First.Last@agenusbio.comJohn.Doe@agenusbio.com
90%
FLast@agenusbio.comJDoe@agenusbio.com
9%
First.Middle@agenusbio.comJohn.Michael@agenusbio.com
1%

Frequently Asked Questions

Where is Agenus's headquarters located?

Minus sign iconPlus sign icon
Agenus's main headquarters is located at 3 Forbes Road Lexington, Massachusetts 02421 United States. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is Agenus's phone number?

Minus sign iconPlus sign icon
You can contact Agenus's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Agenus's stock symbol?

Minus sign iconPlus sign icon
Agenus is a publicly traded company; the company's stock symbol is AGEN.

What is Agenus's official website and social media links?

Minus sign iconPlus sign icon
Agenus's official website is agenusbio.com and has social profiles on LinkedInCrunchbase.

What is Agenus's SIC code NAICS code?

Minus sign iconPlus sign icon
Agenus's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Agenus have currently?

Minus sign iconPlus sign icon
As of April 2026, Agenus has approximately 199 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: G. A.Chief Executive Officer: R. D.Chief Executive Officer: T. L.. Explore Agenus's employee directory with LeadIQ.

What industry does Agenus belong to?

Minus sign iconPlus sign icon
Agenus operates in the Biotechnology Research industry.

What technology does Agenus use?

Minus sign iconPlus sign icon
Agenus's tech stack includes WordPressFont AwesomeCulture AmpjQuery UIAgiloftHSTSAkamai Web Application ProtectorAdobe Tag Manager.

What is Agenus's email format?

Minus sign iconPlus sign icon
Agenus's email format typically follows the pattern of First.Last@agenusbio.com. Find more Agenus email formats with LeadIQ.

How much funding has Agenus raised to date?

Minus sign iconPlus sign icon
As of April 2026, Agenus has raised $16M in funding. The last funding round occurred on Jun 03, 2025 for $16M.

When was Agenus founded?

Minus sign iconPlus sign icon
Agenus was founded in 1994.

Agenus

Biotechnology ResearchMassachusetts, United States51-200 Employees

Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. 

For more information, visit www.agenusbio.com or follow us at @agenus_bio. 

Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/

Section iconCompany Overview

Headquarters
3 Forbes Road Lexington, Massachusetts 02421 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
AGEN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1994
Employees
51-200

Section iconFunding & Financials

  • $16M

    Agenus has raised a total of $16M of funding over 10 rounds. Their latest funding round was raised on Jun 03, 2025 in the amount of $16M.

  • $100M$250M

    Agenus's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $16M

    Agenus has raised a total of $16M of funding over 10 rounds. Their latest funding round was raised on Jun 03, 2025 in the amount of $16M.

  • $100M$250M

    Agenus's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.